Identification of the resistance mechanism to CDK4/6 inhibition and novel overcoming combination therapy with RNR inhibition for chemo-resistant bladder cancer
收藏Mendeley Data2024-01-31 更新2024-06-26 收录
下载链接:
https://data.mendeley.com/datasets/3x9z4rwdrw
下载链接
链接失效反馈官方服务:
资源简介:
The identification of 42 down-regulated protein candidates in treated T24 cells and 46 in RT112 cells compared to the PBS control with 18 overlapping proteins (Supplementary Table S1); At the different time points, 2596, 3674 and 1994 genes were identified as differentially expressed genes (DEGs) (Supplementary Table S2, 3, 4); Identified activation of enormous genes that may confer acquired resistance to CDK4/6 inhibition after 7 days of CDK4/6 inhibition by a CRISPR-dCas9 activation functional genomics analysis, to further narrow down the functional candidates, we applied LFC>1 and FDR<0.001 and identified 365 potential candidates in this study (Supplementary Table S5); To further investigate the potential biological interaction network of RRM2 in clinical bladder cancer specimen, we inquired RRM2 in the TCGA cohorts for mRNA co-expression. Through this analysis, we identified the top 10 correlated genes: KIF18B, SKA3, FANCA, MYBL2, CENPA, FAM72B, IQGAP3, E2F1, FAM72D and CDT1 ranked by Spearman's Correlation (Supplementary Table S6); The informaton of prospectively collected 20 MIBC bladder cancer specimens from patients who received radical cystectomy in our hospital. Patients were divided into 3 subgroups according to therapy naïve, chemotherapy responsive and chemotherapy resistance (Supplementary Table S7)
与磷酸盐缓冲液(Phosphate Buffered Saline, PBS)对照组相比,处理后的T24细胞中鉴定出42个下调蛋白候选物,RT112细胞中鉴定出46个,其中18个为两者共有蛋白(补充表S1);在不同时间点下,共鉴定出2596、3674和1994个差异表达基因(Differentially Expressed Genes, DEGs)(补充表S2、S3、S4);本研究通过CRISPR-dCas9激活功能基因组学分析,发现经CDK4/6抑制剂(Cyclin-Dependent Kinase 4/6 Inhibitor, CDK4/6 Inhibitor)处理7天后,大量基因被激活,这些基因可能赋予细胞对CDK4/6抑制剂的获得性耐药;为进一步筛选功能候选基因,我们设置log2倍数变化(Log2 Fold Change, LFC)>1且错误发现率(False Discovery Rate, FDR)<0.001的筛选阈值,最终鉴定出365个潜在候选基因(补充表S5);为进一步探究RRM2在临床膀胱癌标本中的潜在生物学相互作用网络,我们在癌症基因组图谱(The Cancer Genome Atlas, TCGA)队列中检索RRM2的mRNA共表达情况;通过该分析,我们基于斯皮尔曼相关性(Spearman's Correlation)排序得到前10个相关基因:KIF18B、SKA3、FANCA、MYBL2、CENPA、FAM72B、IQGAP3、E2F1、FAM72D及CDT1(补充表S6);本研究前瞻性收集了我院接受根治性膀胱切除术的20例肌层浸润性膀胱癌(Muscle-Invasive Bladder Cancer, MIBC)患者标本;根据患者初始未治疗、化疗应答及化疗耐药情况,将其分为3个亚组(补充表S7)
创建时间:
2024-01-31



